myeloma {asbio} | R Documentation |
Patient responses to myeloma drug treatments
Description
Murakami et al. (1997) studied the effect of drugs treatments on levels of serum beta-2 microglobulin in patients with multiple myeloma. Serum beta-2 microglobulin is produced in the body as a result of myelomas, and thus can be used as an indicator of the severity of disease
Usage
data(myeloma)
Format
A data frame with 20 observations on the following 2 variables.
mglobulin
Levels of serum beta-2 microglobulin in mg/l
drug
Drug treatment strategy.
Control
= sumerifon alone,Trt
= malphalan and sumerifon.
Source
Ott, R. L., and M. T. Longnecker (2004) A First Course in Statistical Methods. Thompson.
References
Murakami, H., Ogawara, H., Morita, K., Saitoh, T., Matsushima, T., Tamura, J., Sawamura, M., Karasawa, M., Miyawaki, M.,, Schimano, S., Satoh, S., and J Tsuchiy (1997) Serum beta-2-microglobulin in patients with multiple myeloma treated with alpha interferon. Journal of Medicine 28(5-6):311-8.